Copanlisib
| Catalog No. | KMC222001 |
|---|---|
| CAS No. | 1032568-63-0 |
| Formula | C23H28N8O4 |
| FW | 480.5 |
| Unit | Price | Stock |
|---|---|---|
| 100 mg | Enquire | Enquire |
| Chemical Name: | 2-Amino-N-(7-methoxy-8-(3-morpholinopropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)pyrimidine-5-carboxamide |
|---|---|
| Purity: | >95% |
| Storage: | Store at 2-8 deg. C for long term storage |
| Shipping: | Product is stable to be Shipped at Room Temperature |
Copanlisib is chemically 2-Amino-N-(7-methoxy-8-(3-morpholinopropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)pyrimidine-5-carboxamide .
Copanlisib is supplied with detailed characterization data compliant with regulatory guideline.
Copanlisib can be used for the analytical method development, method validation (AMV), Quality Controlled (QC)
application for Abbreviated New Drug Application (ANDA) or during commercial production of Copanlisib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. K.M.Pharma products are for analytical purpose only and not for human use.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. K.M.Pharma products are for analytical purpose only and not for human use.
Related Products
CAT No: KMC222002
CAT No: KMC222003
CAT No: KMC222004
CAT No: KMC222005
CAT No: KMC222006
CAT No: KMC222007
CAT No: KMC222008
CAT No: KMC222009
CAT No: KMC222010
CAT No: KMC222011
CAT No: KMC222012
CAT No: KMC222013
CAT No: KMC222014
CAT No: KMC222015
CAT No: KMC222016
CAT No: KMC222017
CAT No: KMC222018
CAT No: KMC222019
CAT No: KMC222020
CAT No: KMC222021
CAT No: KMC222022
CAT No: KMC222023
CAT No: KMC222024
CAT No: KMC222025
CAT No: KMC222026
CAT No: KMC222027
CAT No: KMC222028
CAT No: KMC222029
